Prevalence and socio-demographic factors of SARS-CoV-2 antibody in multi-ethnic healthcare workers.
Clin Med (Lond)
; 21(1): e5-e8, 2021 Jan.
Article
em En
| MEDLINE
| ID: mdl-33479076
ABSTRACT
INTRODUCTION:
Healthcare workers are particularly susceptible to developing COVID-19 owing to close and frequent contact with COVID-19 patients. This cross-sectional study aimed to describe prevalence of SARS-CoV-2 antibodies among healthcare workers within a hospital trust and examine factors associated with increased prevalence of this antibody.METHODS:
Data was obtained over a 4-week period in 2020 from a cross-sectional prospective survey of healthcare workers serving a multi-ethnic inner-city population who had immunoglobulin G SARS-CoV-2 antibody test. Anonymised socio-demographic data about staff were cross-referenced with these tests.RESULTS:
Of 7,013 staff, 6,212 (89%) undertook the antibody test during this period. Overall detection rate was 26% (1,584/6,212). Univariate analyses revealed no differences in prevalence in terms of gender or age. Compared with white staff members (18%), rates were higher in black (38%) and Asian (27%) members (p<0.001). The rates in general wards (43%) were higher compared with other areas; in emergency medicine and intensive care, prevalence was 23% (p<0.001). Regarding professional groups, prevalence was highest among nursing and allied clinical services (28%), less in doctors (23%) and lower in non-clinical staff (19%).DISCUSSION:
This large study has described prevalence of recent exposure to SARS-CoV-2 infection among healthcare workers and determined associations including ethnicity, professional groups and geographical areas within healthcare settings. This information will be useful in future COVID-19 studies examining the role of antibody testing both in general populations and in healthcare settings.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Etnicidade
/
Pessoal de Saúde
/
Pandemias
/
SARS-CoV-2
/
COVID-19
/
Anticorpos Antivirais
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prevalence_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Clin Med (Lond)
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Reino Unido